Our workforce consists of seasoned professionals in the pharmaceutical industry across the tasks of Clinical Data Management, Statistical Analysis, and Medical Writing. We have been fortunate to build a team of professional, high performing individuals that work well together and with the customer – resulting in very little turnover. Our clients appreciate the opportunity to maintain long term relationships with dedicated resources. Many clients consider IA an extension of their team and turn to IA for support over many years.
Our Management Group
Jim Dancy, BSE, MBA
President, CEO
As the leader of Innovative Analytics, Jim is responsible for advancing the company’s focus on exceptional service. Over the years he has developed an experienced team that is committed to personal attention and world class quality. He is also responsible for business development. Jim co-founded IA in 2003 with Patty Ruppel (retired).
Before Innovative Analytics, Jim held several key positions in data management, including the titles of Director of Clinical Database Operations (Pharmacia) and Director of Experimental Medicine Informatics (Pfizer). While at Pfizer, he implemented a database to support clinical biomarker analysis, which earned a “Best Practices” award in 2003. Jim holds an engineering degree from the University of Michigan and an MBA from Oklahoma University. He achieved Certified Quality Engineer (CQE) status through the American Society for Quality (ASQ).
Gregory Elfring, MA, MS
Executive Director, SAS Programming
Greg joined Innovative Analytics as a partner in 2004 to coordinate and implement the statistical programming services offered by the company. Greg has over 20 years of experience in the pharmaceutical industry as a problem solver providing statistical support and programming for all facets of product development, including discovery research, clinical development, regulatory affairs, and marketing. He has been recognized for his contributions in statistical design, analysis, and inference. An early appreciation of the advantages and limitations of CDISC principles and standards, Greg’s programming group has generated over 50 SDTM and ADaM data packages for current, historical, and integrated studies. He is also an experienced mathematics and statistics instructor and co-developer of educational software for college statistics courses. Greg received graduate degrees in mathematics from Indiana University and in statistics from The Ohio State University.
Kimberly Perry, MS, PhD
Director, Clinical Statistics
Kim joined Innovative Analytics as a partner in 2006 to coordinate, manage, and provide statistical support for clinical studies and registration activities. Kim has over 35 years of experience in the pharmaceutical industry, primarily with Upjohn, Pharmacia, and Pfizer. She received undergraduate training and graduate degrees in biostatistics and mathematics from Western Michigan University. She has provided statistical support for registration and product support programs in the central nervous system and critical care therapeutic areas, as well as for device programs. Kim served as lead statistician for successful US and EU regulatory submissions. Before joining Innovative Analytics, Kim served as a director of clinical biostatistics for 5 years, followed by 3 years in pharmaceutical sciences as a statistical research fellow at Pharmacia/Pfizer. She received the College of Arts and Sciences Outstanding Achievement award from Western Michigan University. Kim is a member of the American Statistical Association (ASA) and was a Trustee of the Kalamazoo Regional Education Service Agency Foundation.
Karen Tindall, BS, CCDM
Director, Data Management
Karen Tindall, Director of Data Management is a proven clinical data management expert. Karen has been a Certified Clinical Data Manager (CCDM) through the Society for Clinical Data Management (SCDM) since the inception of the program in 2005. She has written test questions for the SCDM Certification Exam, been a DIA webcast instructor, and created customized workshops on data management.
Lillian Neff, BA
Executive Director, Medical Writing
Lillian, Executive Director of Medical Writing, has extensive hands-on experience in writing all types of clinical drug development documents, from Investigational New Drug Applications (INDs) through registration documents in the Common Technical Document (CTD) format, to advisory committee brochures, to manuscripts. She has written documents across all phases of clinical development in a variety of therapeutic areas, including cardiovascular, central nervous system, and renal diseases; dermatology; oncology; and women’s health, as well as reports for medical devices. Lillian’s prior career in pharma, which spanned more than 25 years, included implementation and monitoring of clinical trials, medical writing, and management. She is member of the American Medical Writers Association (AMWA) and holds a medical writing certificate from that organization.
Sue Thayer, BSEE, MS
Director Business Operations & Quality Assurance
As Director of Business Operations, Sue manages the initiation, coordination, and updating of all project related business contracts. These responsibilities include Requests for Information, NDAs, MSAs, SOW, and change orders. She has been involved in the business aspects of Innovative Analytics since 2014. As Director of Quality Assurance, Sue oversees the quality management system, manages internal audit activities, and provides vendor oversight.
Sue’s background in clinical research and engineering has provided excellent training and expertise for her current roles. She holds an engineering degree from Purdue University and completed a master's degree in Clinical Research Administration. Sue began her role at Innovative Analytics in 2007 as a data manager and obtained Certified Clinical Data Manager (CCDM) accreditation.